Niacinamide This multi-tasking ingredient helps with brightening, reducing the appearance of pores, and strengthening the skin barrier
Its effective and well-studied, with dosing from 0.25 mg to 2 mg
Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has announced positive topline results from a phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes
The product, geared at optimizing metabolic burn, contains ingredients including African mango seed, said to reduce fat cells
Hints will be plentiful in retrospect